The evolution of farnesoid X, vitamin D, and pregnane X receptors: Insights from the green-spotted pufferfish (Tetraodon nigriviridis) and other non-mammalian species

BMC Biochemistry

Volumn 12, Issue 1, 2011, Pages

  Krasowski, Matthew D ^a,b   Ai, Ni ^c   Hagey, Lee R ^d   Kollitz, Erin M ^e   Kullman, Seth W ^e   Reschly, Erica J ^b   Ekins, Sean ^c,f,g  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e NORTH CAROLINA STATE UNIVERSITY   (United States)

^f Collaborations in Chemistry ^*  (United States)

^g UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [2 [2 CHLORO 4 [3 (2,6 DICHLOROPHENYL) 5 ISOPROPYL 4 ISOXAZOLYLMETHOXY]PHENYL]VINYL]BENZOIC ACID; CHENODEOXYCHOLIC ACID; CHOLESTEROL; FARNESOID X RECEPTOR; LITHOCHOLIC ACID; PREGNANE X RECEPTOR; RIFAMPICIN; VITAMIN D RECEPTOR; BILE ACID; CALCITRIOL RECEPTOR; CELL RECEPTOR; FARNESOID X-ACTIVATED RECEPTOR; LIGAND; STEROID RECEPTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; LAMPREY; LIGAND BINDING; MOLECULAR DOCKING; MOLECULAR EVOLUTION; MOLECULAR MODEL; MOUSE; NONHUMAN; ORYZIAS; PHARMACOPHORE; PROTEIN STRUCTURE; RAT; RECEPTOR AFFINITY; RECEPTOR BINDING; RECEPTOR UPREGULATION; SEQUENCE HOMOLOGY; SPECIES DIVERSITY; TETRAODONTIFORMES; ZEBRA FISH; ANIMAL; CHEMICAL STRUCTURE; GENETICS; METABOLISM; PROTEIN DOMAIN; SPECIES DIFFERENCE; STRUCTURE ACTIVITY RELATION;

DANIO RERIO; MAMMALIA; ORYZIAS LATIPES; PETROMYZON MARINUS; PETROMYZONTIDAE; RATTUS; TETRAODON; TETRAODONTIDAE; VERTEBRATA; XENOPUS LAEVIS;

ANIMALS; BILE ACIDS AND SALTS; EVOLUTION, MOLECULAR; HUMANS; LIGANDS; MICE; MODELS, MOLECULAR; PROTEIN INTERACTION DOMAINS AND MOTIFS; RATS; RECEPTORS, CALCITRIOL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, STEROID; SPECIES SPECIFICITY; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAODONTIFORMES; ZEBRAFISH;

EID: 79551562608     PISSN: None     EISSN: 14712091     Source Type: Journal    
DOI: 10.1186/1471-2091-12-5     Document Type: Article

References (81)

1. Huang P, Chandra V, Rastinejad F: Structural overview of the nuclear receptor superfamily: insights into physiology and therapeutics. Annu Rev Physiol 2010, 72:247-272.
2. McEwan IJ: Nuclear receptors: one big family. Methods Mol Biol 2009, 505:3-18.
3. Steinmetz ACU, Renaud J-P, Moras D: Binding of ligands and activation of transcription by nuclear receptors. Annu Rev Biophys Biomol Struct 2001, 30:329-359. (Pubitemid 32566167)
4. Moore LB, Maglich JM, McKee DD, Wisely B, Willson TM, Kliewer SA, Lambert MH, Moore JT: Pregnane X receptor (PXR), constitutive androstane receptor (CAR), and benzoate X receptor (BXR) define three pharmacologically distinct classes of nuclear receptors. Mol Endocrinol 2002, 16:977-986. (Pubitemid 34478535)
5. Moore LB, Parks DJ, Jones SA, Bledsoe RK, Consler TG, Stimmel JB, Goodwin B, Liddle C, Blanchard SG, Willson TM, et al: Orphan nuclear receptors constitutive androstane receptor and pregnane X receptor share xenobiotic and steroid ligands. J Biol Chem 2000, 275:15122-15127. (Pubitemid 30337234)
6. Krasowski MD, Yasuda K, Hagey LR, Schuetz EG: Evolutionary selection across the nuclear hormone receptor superfamily with a focus on the NR1I subfamily (vitamin D, pregnane X, and constitutive androstane receptors). Nucl Recept 2005, 3:2.
7. Krasowski MD, Yasuda K, Hagey LR, Schuetz EG: Evolution of the pregnane X receptor: adaptation to cross-species differences in biliary bile salts. Mol Endocrinol 2005, 19:1720-1739. (Pubitemid 41007886)
8. Iyer M, Reschly EJ, Krasowski MD: Functional evolution of the pregnane X receptor. Expert Opin Drug Metab Toxicol 2006, 2:381-387.
9. Reschly EJ, Ai N, Ekins S, Welsh WJ, Hagey LR, Hofmann AF, Krasowski MD: Evolution of the bile salt nuclear receptor FXR in vertebrates. J Lipid Res 2008, 49:1577-1587.
10. Reschly EJ, Bainy ACD, Mattos JJ, Hagey LR, Bahary N, Mada SR, Ou J, Venkataramanan R, Krasowski MD: Functional evolution of the vitamin D and pregnane X receptors. BMC Evol Biol 2007, 7:222.
11. Reschly EJ, Krasowski MD: Evolution and function of the NR1I nuclear hormone receptor subfamily (VDR, PXR, and CAR) with respect to metabolism of xenobiotics and endogenous compounds. Curr Drug Metab 2006, 7:349-365.
12. Schuetz EG, Strom S, Yasuda K, Lecureur V, Assem M, Brimer C, Lamba J, Kim RB, Ramachandran V, Komoroski BJ, et al: Disrupted bile acid homeostasis reveals an unexpected interaction among nuclear hormone receptors, transporters, and cytochrome P450. J Biol Chem 2001, 276:39411-39418. (Pubitemid 37371319)
13. Hofmann AF, Hagey LR, Krasowski MD: Bile salts of vertebrates: structural variation and possible evolutionary significance. J Lipid Res 2010, 51:226-246.
14. Hofmann AF, Eckmann L: How bile acids confer gut mucosal protection against bacteria. Proc Natl Acad Sci USA 2006, 103:4333-4334.
15. Hofmann AF, Hagey LR: Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci 2008, 65:2461-2483.
16. Haslewood GAD: Bile salt evolution. J Lipid Res 1967, 8:535-550.
17. Moschetta A, Xu F, Hagey LR, van Berge Henegouwen GP, van Erpecum KJ, Brouwers JF, Cohen JC, Bierman M, Hobbs HH, Steinbach JH, et al: A phylogenetic survey of biliary lipids in vertebrates. J Lipid Res 2005, 46:2221-2232. (Pubitemid 41377474)
18. Une M, Hoshita T: Natural occurrence and chemical synthesis of bile alcohols, higher bile acids, and short side chain bile acids. Hiroshima J Med Sci 1994, 43:37-67.
19. Norlin M, Wikvall K: Enzymes in the conversion of cholesterol into bile acids. Curr Mol Med 2007, 7:199-218. (Pubitemid 46488191)
20. Russell DW: The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem 2003, 72:137-174.
21. Hofmann AF: Detoxification of lithocholic acid, a toxic bile acid: relevance to drug hepatotoxicity. Drug Metab Rev 2004, 36:703-722.
22. Goto T, Holzinger F, Hagey LR, Cerrè C, Ton-Nu H-T, Schteingart CD, Steinbach JH, Shneider BL, Hofmann AF: Physicochemical and physiological properties of 5a-cyprinol sulfate, the toxic bile salt of cyprinid fish. J Lipid Res 2003, 44:1643-1651. (Pubitemid 37185874)
23. Hagey LR, Møller PR, Hofmann AF, Krasowski MD: Diversity of bile salts in fish and amphibians: evolution of a complex biochemical pathway. Physiol Biochem Zool 2010, 83:308-321.
24. Hagey LR, Vidal N, Hofmann AF, Krasowski MD: Evolutionary diversity of bile salts in reptiles and mammals, including analysis of ancient human and extinct giant ground sloth coprolites. BMC Evol Biol 2010, 10:133.
25. Hagey LR, Vidal N, Hofmann AF, Krasowski MD: Complex evolution of bile salts in birds. Auk 2010, 127:820-831.
26. Kliewer SA, Willson TM: Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor. J Lipid Res 2002, 43:359-364. (Pubitemid 34252265)
27. Orans J, Teotico DG, Redinbo MR: The nuclear xenobiotic receptor PXR: recent insights and new challenges. Mol Endocrinol 2005, 19:2891-2900. (Pubitemid 41697709)
28. Sonoda J, Xie W, Rosenfeld JM, Barwick JL, Guzelian PS, Evans RM: Regulation of a xenobiotics sulfonation cascade by nuclear pregnane X receptor (PXR). Proc Natl Acad Sci USA 2002, 99:13801-13806. (Pubitemid 35215461)
29. Ekins S, Reschly EJ, Hagey LR, Krasowski MD: Evolution of pharmacologic specificity in the pregnane X receptor. BMC Evol Biol 2008, 8:103.
30. Chrencik JE, Orans J, Moore LB, Xue Y, Peng L, Collins JL, Wisely GB, Lambert MH, Kliewer SA, Redinbo MR: Structural disorder in the complex of human PXR and the macrolide antibiotic rifampicin. Mol Endocrinol 2005, 19:1125-1134. (Pubitemid 40594113)
31. Watkins RE, Davis-Searles PR, Lambert MH, Redinbo MR: Coactivator binding promotes the specific interaction between ligand and the pregnane X receptor. J Mol Biol 2003, 331:815-828. (Pubitemid 36945439)
32. Watkins RE, Maglich JM, Moore LB, Wisely GB, Noble SM, Davis-Searles PR, Lambert MH, Kliewer SA, Redinbo MR: 2.1 Å crystal structure of human PXR in complex with the St. John's wort compound hyperforin. Biochemistry 2003, 42:1430-1438.
33. Watkins RE, Wisely GB, Moore LB, Collins JL, Lambert MH, Williams SP, Willson TM, Kliewer SA, Redinbo MR: The human nuclear xenobiotic receptor PXR: structural determinants of directed promiscuity. Science 2001, 292:2329-2333. (Pubitemid 32568055)
34. Xue Y, Chao E, Zuercher WJ, Willson TM, Collins JL, Redinbo MR: Crystal structure of PXR-T1317 complex provides a scaffold to examine the potential for receptor antagonism. Bioorg Med Chem 2007, 15:2156-2166. (Pubitemid 46176620)
35. Xue Y, Moore LB, Orans J, Peng L, Bencharit S, Kliewer SA, Redinbo MR: Crystal structure of PXR-estradiol complex provides insights into endobiotic recognition. Mol Endocrinol 2007, 21:1028-1038. (Pubitemid 46984756)
36. Kalaany NY, Mangelsdorf DJ: LXRs and FXR: the Yin and Yang of cholesterol and fat metabolism. Annu Rev Physiol 2006, 68:159-191.
37. Makishima M, Okamato AY, Repa JJ, Tu H, Learned RM, Luk A, Hull MV, Lustig KD, Mangelsdorf DJ, Shan B: Identification of a nuclear receptor for bile acids. Science 1999, 284:1362-1365. (Pubitemid 29289663)
38. Parks DJ, Blanchard SG, Bledsoe RK, Chandra G, Consler TG, Kliewer SA, Stimmel JB, Willson TM, Zavacki AM, Moore DD, et al: Bile acids: natural ligands for an orphan nuclear receptor. Science 1999, 284:1365-1368. (Pubitemid 29289664)
39. Wang H, Chen J, Hollister K, Sowers LC, Forman BM: Endogenous bile acids are ligands for the nuclear receptor FXR/BAR. Mol Cell 1999, 3:543-553. (Pubitemid 29268438)
40. Otte K, Kranz H, Kober I, Thompson P, Hoefer M, Haubold B, Remmel B, Voss H, Kaiser C, Albers M, et al: Identification of farnesoid X receptor b as a novel mammalian nuclear receptor sensing lanosterol. Mol Cell Biol 2003, 23:864-872. (Pubitemid 36133505)
41. Seo Y-W, Sanyal S, Kim H-J, Won DH, An J-Y, Amano T, Zavacki AM, Kwon H-B, Shi Y-B, Kim W-S, et al: FOR, a novel orphan nuclear receptor related to farnesoid X receptor. J Biol Chem 2002, 277:17836-17844.
42. Dusso AS, Brown AJ, Slatopolsky E: Vitamin D. Am J Physiol Renal Physiol 2005, 289:F8-F28. (Pubitemid 40863568)
43. Holick MF: Evolution and function of vitamin D. Recent Results Cancer Res 2003, 164:3-28.
44. Kira M, Kobayashi T, Yoshikawa K: Vitamin D and the skin. J Dermatol 2003, 30:429-437. (Pubitemid 36829970)
45. Moro JR, Iwata M, von Andriano UH: Vitamin effects on the immune system: vitamins A and D take centre stage. Nat Rev Immunol 2008, 8:685-698.
46. Bertrand S, Thisse B, Tavares R, Sachs L, Chaumot A, Bardet PL, Escriva H, Duffraisse M, Marchand O, Safi R, et al: Unexpected novel relational links uncovered by extensive developmental profiling of nuclear receptor expression. PLoS Genet 2007, 3:e188.
47. Jaillon O, Aury J-M, Brunet F, Petit J-L, Strange-Thomann N, Mauceli E, Bouneau L, Fischer C, Ozouf-Costaz C, Bernot A, et al: Genome duplication in the telost fish Tetraodon nigroviridis reveals the early vertebrate proto-karyotype. Nature 2004, 431:946-956.
48. Maglich JM, Caravella JA, Lambert MH, Willson TM, Moore JT, Ramamurthy L: The first completed genome sequence from a teleost fish (Fugu rubripes) adds significant diversity to the nuclear receptor superfamily. Nucleic Acids Res 2003, 31:4051-4058. (Pubitemid 37442285)
49. Howarth DL, Law SH, Barnes B, Hall JM, Hinton DE, Moore L, Maglich JM, Moore JT, Kullman SW: Paralogous vitamin D receptors in teleosts: transition of nuclear receptor function. Endocrinology 2008, 149:2411-2422. (Pubitemid 351574525)
50. Adachi R, Honma Y, Masuno H, Karana K, Shimomura I, Yamada S, Makishima M: Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J Lipid Res 2005, 46:46-57. (Pubitemid 40066670)
51. Adachi R, Shulman AI, Yamamoto K, Shimomura I, Yamada S, Mangelsdorf DJ, Makishima M: Structural determinants for vitamin D responses to endocrine and xenobiotic signals. Mol Endocrinol 2004, 18:43-52. (Pubitemid 38073152)
52. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM, Haussler MR, Mangelsdorf DJ: Vitamin D receptor as an intestinal bile acid sensor. Science 2002, 296:1313-1316. (Pubitemid 34522785)
53. Chow EC, Maeng HJ, Liu S, Khan AA, Groothuis GM, Pang KS: 1alpha,25-dihydroxyvitamin D(3) triggered vitamin D receptor and farnesoid X receptor-like effects in rat intestine and liver in vivo. Biopharm Drug Dispos 2009.
54. Matsubara T, Yoshinari K, Aoyama K, Sugawara M, Sekiya Y, Nagata K, Yamazoe Y: Role of vitamin D receptor in the lithocholic acid-mediated CYP3A induction in vitro and in vivo. Drug Metab Dispos 2008, 36:2058-2063.
55. Pavek P, Pospechova K, Svecova L, Syrova Z, Stejskalova L, Blazkova J, Dvorak Z, Blahos J: Intestinal cell-specific vitamin D receptor (VDR)-mediated transcriptional regulation of CYP3A4 gene. Biochem Pharmacol 2009.
56. Thummel KE, Brimer C, Yasuda K, Thottassery J, Senn T, Lin Y, Ishizuka H, Kharasch E, Schuetz J, Schuetz E: Transcriptional control of intestinal cytochrome P-4503A by 1a,25-dihydroxy vitamin D3. Mol Pharmacol 2001, 60:1399-1406. (Pubitemid 33144911)
57. Hagey LR, Iida T, Ogawa S, Kakiyama G, Asahina K, Mushiake K, Goto T, Mano N, Goto J, Krasowski MD, et al: Major biliary bile acids of the Medaka (Oryzias latipes): 25R- and 25S epimers of 3α,7α,12α- trihydroxy- 5β-cholestanoic acid. Zool Sci 2010, 27:565-573.
58. Howarth DL, Hagey LR, Law SHW, Ai N, Krasowski MD, Ekins S, Moore JT, Kollitz EM, Hinton DE, Kullman SW: Two farnesoid X receptor a isoforms in Japanese medaka (Orzias latipes) are differentially activated in vitro. Aquat Toxicol 2010, 98:245-255.
59. Mi L-Z, Devarakonda S, Harp JM, Han Q, Pellicciari R, Willson TM, Khorasanizadeh S, Rastinejad F: Structural basis for bile acid binding and activation of the nuclear receptor FXR. Mol Cell 2003, 11:1093-1100. (Pubitemid 36566329)
60. Downes M, Verdecia MA, Roecker AJ, Hughes R, Hogenesch JB, Kast- Woelbern HR, Bowman ME, Ferrer J-L, Anisfeld AM, Edwards PA, et al: A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR. Mol Cell 2003, 11:1079-1092. (Pubitemid 36566328)
61. Houck KA, Borchert KM, Hepler CD, Thomas JS, Bramlett KS, Michael LF, Burris TP: T0901317 is a dual LXR/FXR agonist. Mol Genet Metab 2004, 83:184-187. (Pubitemid 39311292)
62. Mitro N, Vargas L, Romeo R, Koder A, Saez E: T0901317 is a potent PXR ligand: implications for the biology ascribed to LXR. FEBS Lett 2007, 581:1721-1726. (Pubitemid 46602262)
63. Blumberg B, Kang H, Bolado J, Chen H, Craig AG, Moreno TA, Umesano K, Perlmann T, De Robertis EM, Evans RM: BXR, an embryonic orphan nuclear receptor activated by a novel class of endogenous benzoate metabolites. Genes Dev 1998, 12:1269-1277. (Pubitemid 28213403)
64. Ekins S, Erickson JA: A pharmacophore for human pregnane X receptor ligands. Drug Metab Dispos 2002, 30:96-99. (Pubitemid 34016946)
65. Ekins S, Kortagere S, Iyer M, Reschly EJ, Lill MA, Redinbo MR, Krasowski MD: Challenges predicting ligand-receptor interactions of promiscuous proteins: the nuclear receptor PXR. PLoS Comput Biol 2009, 5:e1000594.
66. Krasowski MD, Ni A, Hagey LR, Ekins S: Evolution of promiscuous nuclear hormone receptors: LXR, FXR, VDR, PXR, and CAR. Mol Cell Endocrinol 2010.
67. Howarth DL, Law SH, Law JM, Mondon JA, Kullman SW, Hinton DE: Exposure to the synthetic FXR agonist GW4064 causes alterations in gene expression and sublethal hepatotoxicity in eleutheroembryo medaka (Oryzias latipes). Toxicol Appl Pharmacol 2010, 243:111-121.
68. Cai SY, Xiong L, Wray CG, Ballatori N, Boyer JL: The farnesoid X receptor, FXRa/NR1H4, acquired ligand specificity for bile salts late in vertebrate evolution. Am J Physiol Regul Integr Comp Physiol 2007, 293:R1400-R1409. (Pubitemid 47358967)
69. Bachmann K, Patel H, Batayneh Z, Slama J, White D, Posey J, Ekins S, Gold D, Sambucetti L: PXR and the regulation of apoA1 and HDLcholesterol in rodents. Pharmacol Res 2004, 50:237-246. (Pubitemid 38844476)
70. Schuster D, Langer T: The identification of ligand features essential for PXR activation. J Med Chem 2005, 45:431-439. (Pubitemid 40642597)
71. Ciesielski F, Rochel N, Mitschler A, Kouzmenko A, Moras D: Structural investigation of the ligand binding domain of the zebrafish VDR in complexes with 1alpha,25(OH)2D3 and Gemini: purification, crystallization and preliminary X-ray diffraction analysis. J Steroid Biochem Mol Biol 2004, 89-90:55-59. (Pubitemid 38844260)
72. Ciesielski F, Rochel N, Moras D: Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation. J Steroid Biochem Mol Biol 2007, 103:235-242. (Pubitemid 46401297)
73. Rochel N, Tocchini-Valentini G, Egea PF, Juntunen K, Garnier J-M, Vihko P, Moras D: Functional and structural characterization of the insertion region in the ligand binding domain of the vitamin D nuclear receptor. Eur J Biochem 2001, 268:971-979. (Pubitemid 32328341)
74. Rochel N, Wurtz JM, Mitschler A, Klaholz B, Moras D: The crystal structure of the nuclear receptor for vitamin D bound to its natural ligand. Mol Cell 2000, 5:173-179. (Pubitemid 30105446)
75. Rossi SS, Converse JL, Hofmann AF: High pressure liquid chromatography analysis of conjugated bile acids in human bile: simultaneous resolution of sulfated and unsulfated lithocholyl amidates and the common conjugated bile acids. J Lipid Res 1987, 28:589-595. (Pubitemid 17116189)
76. Ensembl genome browser. [http://www.ensembl.org].
77. Reschly EJ, Ai N, Welsh WJ, Ekins S, Hagey LR, Krasowski MD: Ligand specificity and evolution of liver X receptors. Journal of Steroid Biochemistry and Molecular Biology 2008, 110:83-94.
78. Clement OO, Mehl AT: HipHop: pharmacophore based on multiple common-feature alignments. In Pharmacophore perception, development, and use in drug design. Edited by: Guner OF. San Diego: IUL; 2000:69-84.
79. Diao L, Ekins S, Polli JE: Novel inhibitors of human organic cation/ carnitine transporter (hOCTN2) via computational modeling and in vitro testing. Pharm Res 2009, 26:1890-1900.
80. Liang J, Edelsbrunner H, Woodward C: Anatomy of protein pockets and cavities: measurement of binding site geometry and implications for ligand design. Protein Sci 1998, 7:1884-1897. (Pubitemid 28432430)
81. Jones G, Willett P, Glen RC, Leach AR, Taylor R: Development and validation of a genetic algorithm for flexible docking. J Mol Biol 1997, 267:727-748. (Pubitemid 27170693)